NeoGenomics Reports 17% Revenue Growth to Record $69 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Neogenomics (NEO) PT Raised to $22 at Craig-Hallum
October 30, 2018 4:00 PM EDTCraig-Hallum analyst Kevin Ellich raised the price target on Neogenomics (NASDAQ: NEO) to $22.00 while maintaining a Buy rating.
Ellich cited "excellent" Q3 results while the Genoptix deal ads another layer of growth.
... MoreNeogenomics (NEO) FV Raised to $20 at Janney Montgomery Scott
October 30, 2018 12:56 PM EDTJanney Montgomery Scott analyst Paul Knight raised his fair value target on Neogenomics (NASDAQ: NEO) to $20.00 while maintaining a Buy rating following Q3 results.
... More